[
  {
    "ts": null,
    "headline": "Piper Sandler Maintains AbbVie (ABBV) Overweight Recommendation",
    "summary": "Piper Sandler Maintains AbbVie (ABBV) Overweight Recommendation",
    "url": "https://finnhub.io/api/news?id=9fa29e1995748abe2d2c32c08b5bfd97a605ee61242346969897c646c05aff8b",
    "source": "Fintel",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760121664,
      "headline": "Piper Sandler Maintains AbbVie (ABBV) Overweight Recommendation",
      "id": 137044173,
      "image": "",
      "related": "ABBV",
      "source": "Fintel",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=9fa29e1995748abe2d2c32c08b5bfd97a605ee61242346969897c646c05aff8b"
    }
  },
  {
    "ts": null,
    "headline": "Global Protein Drugs Market to Reach $655.7 Billion by 2029",
    "summary": "“BCC Research analyzes how innovation in biomanufacturing, ESG trends, and strategic investments are shaping the next frontier of protein-based therapeutics.”Boston, Oct. 10, 2025 (GLOBE NEWSWIRE) -- As demand for targeted, biologic-based treatments continues to grow, protein drugs are transforming how pharmaceutical companies address chronic, genetic, and life-threatening diseases. From monoclonal antibodies (mAbs) to peptide hormones and vaccines, global leaders such as AbbVie, Novo Nordisk an",
    "url": "https://finnhub.io/api/news?id=4104355162b240b144e9d64246cb9f19d624a2b020f31b23f3cf9c98679a6e21",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760120820,
      "headline": "Global Protein Drugs Market to Reach $655.7 Billion by 2029",
      "id": 137048982,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "“BCC Research analyzes how innovation in biomanufacturing, ESG trends, and strategic investments are shaping the next frontier of protein-based therapeutics.”Boston, Oct. 10, 2025 (GLOBE NEWSWIRE) -- As demand for targeted, biologic-based treatments continues to grow, protein drugs are transforming how pharmaceutical companies address chronic, genetic, and life-threatening diseases. From monoclonal antibodies (mAbs) to peptide hormones and vaccines, global leaders such as AbbVie, Novo Nordisk an",
      "url": "https://finnhub.io/api/news?id=4104355162b240b144e9d64246cb9f19d624a2b020f31b23f3cf9c98679a6e21"
    }
  },
  {
    "ts": null,
    "headline": "Is Trending Stock AbbVie Inc. (ABBV) a Buy Now?",
    "summary": "Zacks.com users have recently been watching AbbVie (ABBV) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",
    "url": "https://finnhub.io/api/news?id=59b5781eb72d1f9f76372d545ec44c9c9dc4fe0f3a190c9d40d7c8fb0aa356fe",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760101205,
      "headline": "Is Trending Stock AbbVie Inc. (ABBV) a Buy Now?",
      "id": 137041503,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Zacks.com users have recently been watching AbbVie (ABBV) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",
      "url": "https://finnhub.io/api/news?id=59b5781eb72d1f9f76372d545ec44c9c9dc4fe0f3a190c9d40d7c8fb0aa356fe"
    }
  },
  {
    "ts": null,
    "headline": "What to Expect From AbbVie's Q3 2025 Earnings Report",
    "summary": "Pharma giant AbbVie is gearing up to announce its third-quarter results by the end of October, and analysts expect a high single-digit growth in earnings.",
    "url": "https://finnhub.io/api/news?id=80081c719c1daf53169986101960e99ba45266d8ef4c7c0a4344a5f4e73d897b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760079543,
      "headline": "What to Expect From AbbVie's Q3 2025 Earnings Report",
      "id": 137041504,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Pharma giant AbbVie is gearing up to announce its third-quarter results by the end of October, and analysts expect a high single-digit growth in earnings.",
      "url": "https://finnhub.io/api/news?id=80081c719c1daf53169986101960e99ba45266d8ef4c7c0a4344a5f4e73d897b"
    }
  }
]